Early atherosclerosis and cardiovascular events

L. Grote, D. Sommermeyer

Source: Eur Respir Monogr 2010; 50: 174-188
Journal Issue: Sleep Apnoea out of print
Disease area: Sleep and breathing disorders

Congress or journal article abstractFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Grote, D. Sommermeyer. Early atherosclerosis and cardiovascular events. Eur Respir Monogr 2010; 50: 174-188

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Neutrophils and the increased risk of cardiovascular events in severe COPD
Source: Annual Congress 2012 - Distinguishing phenotypes and dealing with comorbidities in primary care
Year: 2012

Impact of pulmonary function on cardiovascular disease events in persons with metabolic syndrome and diabetes
Source: Annual Congress 2011 - Comorbidities and impact on society of asthma and COPD
Year: 2011

Prevalence of cardiovascular risk factors and coronary artery disease in patients with COPD
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010

Risk factors for chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2009; 33: 325-331
Year: 2009

In people at high risk of cardiovascular disease, co-existing COPD is not independently associated with macrovascular or microvascular disease
Source: International Congress 2018 – New determinants of cardiovascular morbidity in COPD
Year: 2018

Assessment of cardiovascular comorbidity
Source: Eur Respir Mon 2013; 59: 28-49
Year: 2013

Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD
Source: Eur Respir J 2008; 32: 962-969
Year: 2008

Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD).
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019

Metabolic effects of OSAS and cardiovascular risk
Source: Research Seminar 2007 - Metabolic Aspects of the Obstructive Sleep Apnea Syndrome (OSAS)
Year: 2007

The frequency of chronic thromboembolic pulmonary hypertension and associated risk factors
Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism
Year: 2011

The impact of aging on COPD, cardiovascular comorbidities and systemic inflammation
Source: International Congress 2019 – Cardiovascular comorbidities in COPD
Year: 2019

Chronic asthma and the risk of cardiovascular disease
Source: Eur Respir Monogr 2020; 88: 82-95
Year: 2020

Coronary artery calcification in COPD is associated with adverse functional assessments and mortality
Source: Annual Congress 2012 - COPD is not a pulmonary disease alone
Year: 2012

Periodic leg movements as risk factors for hypertension and cardiovascular diseases
Source: Sleep and Breathing Conference 2017
Year: 2017

COPD and respiratory viral infections as risk factors for the development of cardiovascular events
Source: Virtual Congress 2020 – Prognosis and integrated management of COPD
Year: 2020

Smoking risk in cardiovascular and cerebrovascular diseases
Source: International Congress 2016 – Smoking-related diseases
Year: 2016

Respiratory polygraphy patterns and risk of cardiovascular events in patients with acute coronary syndrome
Source: Virtual Congress 2021 – From phenotyping to different diagnostic tools for sleep breathing disorders
Year: 2021